Safi Bio-manufactured human blood
1 known investors
Safi Biotherapeutics manufactures adult stem-cell derived human red blood cells (mRBCs) as a cell therapy blood transfusion product, aiming to produce them at industrial scale for civilian and military transfusion needs. Its work targets both chronic transfusion indications, such as sickle cell disease, and acute settings including hospitals and battlefields.
Investors · 1
Frequently asked questions
- What does Safi Bio-manufactured human blood do?
- Safi Biotherapeutics manufactures adult stem-cell derived human red blood cells (mRBCs) as a cell therapy blood transfusion product, aiming to produce them at industrial scale for civilian and military transfusion needs. Its work targets both chronic transfusion indications, such as sickle cell disease, and acute settings including hospitals and battlefields.
- Who are Safi Bio-manufactured human blood's investors?
- Safi Bio-manufactured human blood's investors include J2 Ventures.